Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
UBS
Fish and Richardson
McKesson
Cantor Fitzgerald
Baxter
Deloitte
AstraZeneca
Citi
Healthtrust

Generated: October 21, 2017

DrugPatentWatch Database Preview

Etidronate disodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for etidronate disodium and what is the scope of etidronate disodium freedom to operate?

Etidronate disodium
is the generic ingredient in two branded drugs marketed by Mylan, Apil, and Mgi Pharma Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for etidronate disodium. Two suppliers are listed for this compound.

Summary for Generic Name: etidronate disodium

US Patents:0
Tradenames:2
Applicants:3
NDAs:3
Drug Master File Entries: see list4
Suppliers / Packagers: see list2
Bulk Api Vendors: see list28
Clinical Trials: see list166
Therapeutic Class:Metabolic Bone Disease Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:etidronate disodium at DailyMed

Pharmacology for Ingredient: etidronate disodium

Ingredient-typeDiphosphonates
Drug ClassBisphosphonate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apil
DIDRONEL
etidronate disodium
TABLET;ORAL017831-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Mylan
ETIDRONATE DISODIUM
etidronate disodium
TABLET;ORAL075800-002Jan 24, 2003RXNoYes► Subscribe► Subscribe► Subscribe
Mylan
ETIDRONATE DISODIUM
etidronate disodium
TABLET;ORAL075800-001Jan 24, 2003RXNoNo► Subscribe► Subscribe► Subscribe
Mgi Pharma Inc
DIDRONEL
etidronate disodium
INJECTABLE;INJECTION019545-001Apr 20, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Apil
DIDRONEL
etidronate disodium
TABLET;ORAL017831-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: etidronate disodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apil
DIDRONEL
etidronate disodium
TABLET;ORAL017831-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Mgi Pharma Inc
DIDRONEL
etidronate disodium
INJECTABLE;INJECTION019545-001Apr 20, 1987► Subscribe► Subscribe
Apil
DIDRONEL
etidronate disodium
TABLET;ORAL017831-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Apil
DIDRONEL
etidronate disodium
TABLET;ORAL017831-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Apil
DIDRONEL
etidronate disodium
TABLET;ORAL017831-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Apil
DIDRONEL
etidronate disodium
TABLET;ORAL017831-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Mgi Pharma Inc
DIDRONEL
etidronate disodium
INJECTABLE;INJECTION019545-001Apr 20, 1987► Subscribe► Subscribe
Apil
DIDRONEL
etidronate disodium
TABLET;ORAL017831-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Apil
DIDRONEL
etidronate disodium
TABLET;ORAL017831-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Apil
DIDRONEL
etidronate disodium
TABLET;ORAL017831-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
US Department of Justice
Fuji
Accenture
Farmers Insurance
Mallinckrodt
Chinese Patent Office
Daiichi Sankyo
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot